Associate Professor of Urology, Associate Professor of Oncology, Johns Hopkins University School of Medicine
Urology
Dr. Misop Han, MD
|
|
Give Review
Misop works in the field of Urology. He graduated from Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". Misop Han, MD is a published doctor as well. He has 55 publications published. The latest was: Instrument Life for Robot Assisted Laparoscopic Radical Prostatectomy and Partial Nephrectomy: Are Ten Lives for Most Instruments Justified? Misop Han accepts Medicare payments and is listed with Medicare.gov.
Publications
- Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk Men.
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
- Instrument Life for Robot Assisted Laparoscopic Radical Prostatectomy and Partial Nephrectomy: Are Ten Lives for Most Instruments Justified?
- Importance of Reporting The Gleason Score at the Positive Surgical Margin Site: An Analysis of 4,082 Consecutive Radical Prostatectomy Cases.
- Practice patterns and individual variability of surgeons performing radical Prostatectomy at a high volume academic center.
- Is clinical stage T2c prostate Cancer an intermediate- or high-risk disease?
- PTEN loss is associated with upgrading of prostate Cancer from biopsy to radical prostatectomy.
- The Relationship Between the Extent of Extraprostatic Extension and Survival Following Radical Prostatectomy.
- Brachytherapy for Prostate Cancer: Feasible but Oncologic Equivalence Unproven.
- Limitations of assessing value in robotic surgery for prostate Cancer: what data should patients and physicians use to make the best decision?
- Endocavity Ultrasound Probe Manipulators.
- Obesity and Long-Term Survival after Radical Prostatectomy.
- Outcomes of men with an Elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
- Allogeneic versus autologous Blood transfusion and survival after radical prostatectomy.
- Identification of men with the highest risk of early disease recurrence after radical Prostatectomy.
- Robotic ultrasound and needle guidance for prostate Cancer management: review of the contemporary literature.
- Adenocarcinoma of the Prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical Prostatectomy and prognosis.
- Expanded criteria to identify men eligible for active surveillance of low risk prostate Cancer at johns hopkins: a preliminary analysis.
- Very-high-risk localized prostate Cancer: definition and outcomes.
- Pathological and oncologic outcomes for men with positive lymph nodes at radical Prostatectomy: The Johns Hopkins Hospital 30-year experience.
- African American men with very low-risk prostate Cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option f...
- Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate Cancer.
- Preoperative characteristics of men with unfavorable high-Gleason prostate Cancer at radical prostatectomy.
- Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical Prostatectomy (RP): a 20-year institutional experience.
- Ultrasound probe and needle-guide calibration for robotic ultrasound scanning and needle targeting.
- Increased Incidence of Pathologically Nonorgan Confined Prostate Cancer in African-American Men Eligible for Active Surveillance.
- Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate Cancer.
- Prostate specific antigen best practice statement: 2009 update.
- An updated prostate Cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
- Impact of surgical margin status on prostate-Cancer-specific mortality.
- Optimizing the management of high-risk, localized prostate Cancer.
- Geometric evaluation of systematic transrectal ultrasound guided Prostate biopsy.
- Contemporary evaluation of the National Comprehensive Cancer Network prostate Cancer risk classification system.
- Variation in IL10 and other genes involved in the immune response and in oxidation and prostate Cancer recurrence.
- Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical Prostatectomy.
- Causes of Death After Radical Prostatectomy at a Large Tertiary Center.
- Radical prostatectomy outcome in men 65 years old or older with low risk prostate Cancer.
- Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate Cancer.
- Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas.
- Cigarette smoking and prostate Cancer recurrence after prostatectomy.
- Imaging guidance in minimally invasive Prostatectomy.
- Weight gain is associated with an increased risk of prostate Cancer recurrence after prostatectomy in the PSA era.
- The impact of preoperative erectile dysfunction on survival after radical Prostatectomy.
- Prediction of mortality after radical Prostatectomy by Charlson comorbidity index.
- Radical Prostatectomy in older men: survival outcomes in septuagenarians and octogenarians.
- Clinical significance and treatment of biochemical recurrence after definitive therapy for localized prostate Cancer.
- Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate Cancer risk calculator, and prostate-specific antigen le...
- Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate Cancer.
- Impact of body mass index on biochemical recurrence rates after radical Prostatectomy: an analysis utilizing propensity score matching.
- Does laterality of positive needle biopsy in clinical T2a patients with prostate Cancer affect biochemical recurrence-free survival?
- Prostate Cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
- Progression after radical Prostatectomy for men in their thirties compared to older men.
- Nomograms for clinically localized prostate Cancer. Part I: radical prostatectomy.
- Spinal anesthesia does not impact prostate Cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational study.
Schools
Johns Hopkins University School Of Medicine
Johns Hopkins University School Med
Procedures Preformed
- Complete Nephrectomy With Robotic Assistance
- Cystometry
- Cystotomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- View All
Conditions Treated
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- Blood in Urine (Hematuria)
- View All
Doctors Specialties
- Urology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1346290426 | |
| NPPES Provider LastName | HAN | |
| NPPES Provider FirstName | MISOP | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Urology | |
| Total Claim Count | 84.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346290426 |
| Last Name Of The Provider | HAN |
| First Name Of The Provider | MISOP |
| View All |
Similar Doctors
|
|
Dr. David A. Gordon, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George J. Mamo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey K. Mullins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip M. Pierorazio, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Pravin K. Rao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Alexander, MD |
|
|
Dr. Christen A. Alevizatos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anup R. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christian Pavlovich, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Max Kates, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Schoenberg, MD |
|
|
Dr. Gautham R. Churukanti, MD |
|
|
Dr. Nikolai Sopko, MD |
|
|
Dr. James K. Fitzpatrick, MD |